Article info
PDFIndustry watch
New recreational nicotine lozenges, tablets, gummies and gum proliferate on the US market
- Correspondence to Mateusz Borowiecki, Public Health, National Opinion Research Center, Chicago, IL 60603, USA; Borowiecki-Mateusz{at}norc.org
Citation
New recreational nicotine lozenges, tablets, gummies and gum proliferate on the US market
Publication history
- Received August 1, 2022
- Accepted October 14, 2022
- First published November 1, 2022.
Online issue publication
April 19, 2024
Article Versions
- Previous version (1 November 2022).
- Previous version (20 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.